Open AccessMonoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra
Author(s) -
Kseniya Sychevskaya,
С К Кравченко
Publication year - 2022
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2022-17-2-95-106
Subject(s) - monoclonal antibody , pandemic , cd20 , virology , lymphoproliferative disorders , covid-19 , medicine , rituximab , immunology , lymphoma , monoclonal , antibody , monoclonal antibody therapy , pathology , disease , infectious disease (medical specialty)